| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| IMPEL NEUROPHARMA INC | Chief Medical Officer | Common Stock | 97,990 | $28,417 | $0.2900 | 29 Mar 2022 | Direct |
| IMPEL NEUROPHARMA INC | Chief Medical Officer | Stock Option (right to buy) | 0 | 29 Mar 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919122021673-shrewsbury-stephen-b-2022-03-29 | IMPEL NEUROPHARMA INC | 29 Mar 2022 | 2 | +$48,474 | 4 | Chief Medical Officer | 30 Mar 2022, 21:54 |
| /report/000120919122005453-shrewsbury-stephen-b-2022-01-26 | IMPEL NEUROPHARMA INC | 26 Jan 2022 | 1 | $0 | 4 | Chief Medical Officer | 28 Jan 2022, 16:06 |
| /report/000120919121057275-shrewsbury-stephen-b-2021-09-21 | IMPEL NEUROPHARMA INC | 21 Sep 2021 | 6 | +$199,720 | 4 | Chief Medical Officer | 22 Sep 2021, 16:57 |
| /report/000120919121048221-shrewsbury-stephen-b-2021-07-20 | IMPEL NEUROPHARMA INC | 20 Jul 2021 | 1 | $0 | 4 | Chief Medical Officer | 26 Jul 2021, 18:04 |